GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Recruiting · NCT05430373 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors | Solid Tumors, Adult | Recruiting | Phase 1 | 2026-09-14 | NCT05430373 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grit Biotechnology | 19 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chongqing University Cancer Center | Chongqing | China | 1 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 19 |
| The fifth medical center of the General Hospital of the Chinese people's Liberation Army | Beijing | China | 1 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 58 |
| West China School of Medicine/West China Hospital of Sichuan University | Chengdu | China | 1 |